Fluconazole uses
Pro Research Analysisby 
Searched over 200M research papers for "fluconazole uses"
Uses of Fluconazole: A Comprehensive Overview
Introduction to Fluconazole
Fluconazole is a bis-triazole antifungal drug known for its novel pharmacokinetic properties, including metabolic stability and relatively high water solubility, which contribute to its therapeutic activity . It is widely used to treat various fungal infections, both superficial and systemic, and is particularly beneficial for immunocompromised patients .
Treatment of Cutaneous Leishmaniasis
Fluconazole has been shown to be effective in treating cutaneous leishmaniasis caused by Leishmania major. In a controlled trial conducted in Saudi Arabia, patients treated with fluconazole experienced a significantly higher rate of complete lesion healing compared to those who received a placebo. The study concluded that a six-week course of oral fluconazole is a safe and useful treatment for this condition .
Efficacy in Candidiasis
Oropharyngeal and Esophageal Candidiasis
Fluconazole is highly effective in treating oropharyngeal and esophageal candidiasis, particularly in immunocompromised patients, including those with AIDS. It provides rapid relief and eradicates the yeast in 50% to 90% of patients. However, relapse is common in chronically immunocompromised patients, necessitating long-term prophylaxis 25.
Vaginal Candidiasis
A single oral dose of fluconazole has been found to be comparable to standard topical azole therapy in women with acute vaginal candidiasis, making it a convenient treatment option .
Deep-Seated Candidiasis
Preliminary reports indicate that fluconazole is effective against deep-seated candidiasis, resolving infections in the majority of seriously ill patients when administered at doses of 200 to 400 mg once daily .
Onychomycosis Treatment
Fluconazole is also used to treat distal subungual onychomycosis of the toenail caused by dermatophytes. In a multicenter, double-blind study, fluconazole demonstrated high efficacy and safety at doses of 150, 300, and 450 mg given orally once weekly. Clinical success rates were significantly higher in the fluconazole groups compared to placebo, with low relapse rates over a six-month follow-up period .
Prophylactic Use in Cancer Patients
Fluconazole is effective as antifungal prophylaxis in cancer patients undergoing chemotherapy, radiotherapy, or immunotherapy. It significantly reduces the incidence of oral fungal diseases and is more effective than amphotericin B and nystatin in this context . Additionally, fluconazole prophylaxis has been shown to reduce the incidence of invasive candidiasis and Candida colonization in premature infants, with no significant impact on resistance .
Use in Bone Marrow Transplantation
In patients undergoing bone marrow transplantation, fluconazole prophylaxis significantly reduces the incidence of systemic and superficial fungal infections, improves survival rates, and decreases the need for empiric amphotericin B use. It is well-tolerated with no significant toxicity .
HIV-Related Fungal Infections
Fluconazole is used both continuously and episodically to manage oropharyngeal and esophageal candidiasis in HIV-infected patients. Continuous therapy is associated with fewer episodes of candidiasis and invasive fungal infections without increasing the risk of fluconazole-refractory infections . It is also the drug of choice for maintenance therapy against cryptococcal meningitis in AIDS patients .
Pediatric Use
Fluconazole is effective in treating superficial fungal infections in children, particularly tinea capitis. Both daily and weekly regimens have shown success, although further studies are needed to determine optimal treatment protocols .
Conclusion
Fluconazole is a versatile antifungal agent with a broad spectrum of applications, from treating cutaneous leishmaniasis and various forms of candidiasis to providing prophylaxis in immunocompromised patients. Its efficacy, safety, and convenient administration make it a valuable addition to antifungal therapies. Further research will continue to refine its use and expand its applications.
Sources and full results
Most relevant research papers on this topic
Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.
A six-week course of oral fluconazole is a safe and useful treatment for cutaneous leishmaniasis caused by Leishmania major, with shorter healing times and mild side effects.
Effectiveness of fluconazole as antifungal prophylaxis in cancer patients undergoing chemotherapy, radiotherapy, or immunotherapy: systematic review and meta‐analysis
Fluconazole is more effective in reducing oral fungal diseases during cancer treatment than amphotericin B and nystatin, but its effectiveness is low and very low.
Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.
Fluconazole prophylaxis effectively reduces invasive candidiasis and Candida colonization in premature infants, with no impact on resistance.
DOI
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Continuous fluconazole therapy is not associated with a significant risk of fluconazole-refractory orophayngeal candidiasis compared to episodic fluconazole therapy in HIV-infected patients with access to active antiretroviral therapy.
DOI